Covered recipient · General Payments record
KAREN L BAXTER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,826.40
- Reported across 138 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $431.24 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $177.93 | 15 |
| Lilly USA, LLC | $84.89 | 5 |
| Abbott Laboratories | $58.67 | 3 |
| PFIZER INC. | $37.58 | 2 |
| Amgen Inc. | $16.16 | 1 |
| Astellas Pharma US Inc | $14.58 | 1 |
| ABBVIE INC. | $13.97 | 1 |
| DEXCOM, INC. | $13.86 | 1 |
| Acerta Pharma LLC | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.33 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125140987 | CMS |
| Abbott Laboratories | $21.87 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125140983 | CMS |
| Abbott Laboratories | $13.47 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125140985 | CMS |
| ABBVIE INC. | $13.97 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106498033 | CMS |
| Amgen Inc. | $16.16 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117503238 | CMS |
| Astellas Pharma US Inc | $14.58 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502382 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.60 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105460172 | CMS |
| Dexcom, Inc. | $13.86 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153369507 | CMS |
| Lilly USA, LLC | $19.42 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135665091 | CMS |
| Lilly USA, LLC | $18.58 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723953 | CMS |
| Lilly USA, LLC | $18.18 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723951 | CMS |
| Lilly USA, LLC | $13.97 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135665089 | CMS |
| Lilly USA, LLC | $14.74 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135731094 | CMS |
| Novo Nordisk Inc | $16.49 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100280172 | CMS |
| Novo Nordisk Inc | $13.76 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100521733 | CMS |
| Novo Nordisk Inc | $8.30 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100527663 | CMS |
| Novo Nordisk Inc | $4.15 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100586689 | CMS |
| Novo Nordisk Inc | $7.76 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100589345 | CMS |
| Novo Nordisk Inc | $7.12 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100656237 | CMS |
| Novo Nordisk Inc | $7.20 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100232580 | CMS |
| Novo Nordisk Inc | $16.70 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100303245 | CMS |
| Novo Nordisk Inc | $6.77 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100564902 | CMS |
| Novo Nordisk Inc | $15.15 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100593362 | CMS |
| Novo Nordisk Inc | $18.77 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100647499 | CMS |
| Novo Nordisk Inc | $0.77 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100616913 | CMS |
| Novo Nordisk Inc | $16.43 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100381407 | CMS |
| Novo Nordisk Inc | $17.87 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100536351 | CMS |
| Novo Nordisk Inc | $20.69 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100539552 | CMS |
| PFIZER INC. | $18.99 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131263510 | CMS |
| PFIZER INC. | $18.59 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131520447 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.